226 — Seattle, Washington

226 is a clinical research site located in Seattle, Washington, United States 98105.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

226 has participated in 2 clinical trials.

Therapeutic areas: Nonalcoholic Steatohepatitis (NASH).

Sponsors: Corcept Therapeutics.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 226?

226 has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 226 conducted?

226 has 2 clinical trials on record. Their work covers Nonalcoholic Steatohepatitis (NASH).

Is 226 accredited by Crixeo Health?

226 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 226?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.